Side-by-side financials for FBRX and NVS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | FBRX | NVS |
|---|---|---|
| Market cap | - | $292.08 B |
| US-listed rank | - | #47 |
| Revenue (latest FY) | $36.00K | - |
| Net income (latest FY) | -$69.38M | - |
| Net margin | -192708.3% | - |
| SEC filings | 595 | 947 |
Full pages: Forte Biosciences, Inc. and Novartis AG, or browse the full rankings.